Article Sidebar
Published:
Jul 9, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Curcumin inhibits gastric cancer growth via downregulation of zinc finger protein, ZNF139
Abstract
Purpose: To investigate the effect of curcumin on gastric cancer cell proliferation and the mechanism of action involved.
Methods: Viability of gastric cells following curcumin treatment was determined by 3 (4,5 dimethyl thiazol 2 yl) 2,5 diphenyl 2H tetrazolium bromide (MTT) assay. Flow cytometry was used for the assessment of apoptosis induction in SGC 7901 cells. Reverse transcriptase polymerase chain reaction (RT-PCR) and western blotting assay were used for the analysis of Znf139, survivin and Bcl 2 protein expressions.
Results: The results showed that curcumin treatment reduced the viability of gastric cancer cell line SGC 7901 cells at 30 µM concentration to 29.67 % after 48 h compared to 99.78 % for control culture. Apoptotic cell population increased significantly (p < 0.05) following treatment with curcumin. Zinc finger protein-139 mRNA and protein expression decreased significantly (p < 0.05) on treatment with curcumin. Furthermore, curcumin suppressed the levels of B cell lymphoma 2 (Bcl 2) and survivin protein. In the mice model of gastric cancer, treatment with 50 mg/kg dose of curcumin inhibited tumor growth and development significantly, compared to the untreated group (p < 0.05).
Conclusion: The results demonstrate that curcumin treatment inhibits gastric cancer cell proliferation via down-regulation of zinc finger protein-139. It also suppresses tumor growth in mice. Therefore, curcumin is a promising gastric cancer inhibitor and should be further investigated for the management of gastric cancer.
